CX Institutional’s Northrop Grumman NOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.35M Buy
15,194
+13,975
+1,146% +$7.52M 0.2% 123
2026
Q2
$621K Sell
1,219
-201
-14% -$116K 0.02% 414
2026
Q1
$969K Sell
1,420
-133
-9% -$92K 0.03% 345
2025
Q4
$886K Buy
1,553
+111
+8% +$64.4K 0.03% 307
2025
Q3
$879K Buy
1,442
+436
+43% +$247K 0.03% 321
2025
Q2
$503K Buy
1,006
+19
+2% +$9.34K 0.02% 370
2025
Q1
$505K Buy
987
+198
+25% +$94.5K 0.02% 355
2024
Q4
$370K Buy
789
+50
+7% +$25.1K 0.01% 397
2024
Q3
$390K Sell
739
-4,971
-87% -$2.43M 0.02% 414
2024
Q2
$2.49M Buy
5,710
+167
+3% +$76.3K 0.12% 185
2024
Q1
$2.65M Buy
5,543
+4,888
+746% +$2.25M 0.13% 179
2023
Q4
$307K Buy
655
+7
+1% +$3.28K 0.02% 399
2023
Q3
$285K Buy
648
+38
+6% +$16.7K 0.02% 411
2023
Q2
$278K Buy
610
+62
+11% +$28.1K 0.01% 443
2023
Q1
$256K Sell
548
-1,770
-76% -$821K 0.01% 433
2022
Q4
$1.26M Buy
2,318
+77
+3% +$40.2K 0.08% 249
2022
Q3
$1.05M Sell
2,241
-215
-9% -$102K 0.07% 250
2022
Q2
$1.18M Buy
2,456
+264
+12% +$121K 0.09% 227
2022
Q1
$980K Sell
2,192
-13,912
-86% -$5.74M 0.08% 224
2021
Q4
$6.23M Buy
16,104
+4,511
+39% +$1.68M 0.5% 54
2021
Q3
$4.18M Sell
11,593
-76
-0.7% -$27.5K 0.34% 85
2021
Q2
$4.24M Sell
11,669
-303
-3% -$109K 0.35% 85
2021
Q1
$3.88M Buy
11,972
+651
+6% +$196K 0.35% 86
2020
Q4
$3.45M Sell
11,321
-2,547
-18% -$779K 0.33% 76
2020
Q3
$4.38M Buy
13,868
+5,704
+70% +$1.86M 0.47% 57
2020
Q2
$2.51M Buy
8,164
+589
+8% +$193K 0.33% 72
2020
Q1
$2.29M Buy
7,575
+7,498
+9,738% +$2.61M 0.37% 63
2019
Q4
$26K Sell
77
-6,080
-99% -$2.14M ﹤0.01% 322
2019
Q3
$2.31M Sell
6,157
-1,194
-16% -$423K 0.37% 67
2019
Q2
$2.38M Buy
7,351
+7,285
+11,038% +$2.17M 0.38% 65
2019
Q1
$18K Buy
66
+39
+144% +$10.6K ﹤0.01% 407
2018
Q4
$7K Hold
27
– – ﹤0.01% 376
2018
Q3
$9K Hold
27
– – ﹤0.01% 260
2018
Q2
$8K Buy
+27
New +$8.93K ﹤0.01% 241

Other funds holding NOC

CX Institutional's NOC Position: Q3 2026 in Review

CX Institutional increased its Northrop Grumman (NOC) stake by 1,146% in Q3 2026, buying an estimated $7.52M and bringing the position to 15,194 shares worth $7.35M. The position accounts for 0.2% of the portfolio, ranked #123.

CX Institutional first reported a position in NOC in Q2 2018 and has held it in 34 quarters since. 438 funds tracked by Wall St. Rank hold NOC as of Q3 2026.

  • CX Institutional held 15,194 shares of Northrop Grumman worth $7.35M as of Q3 2026.
  • CX Institutional bought 13,975 Northrop Grumman shares in Q3 2026, an estimated $7.52M.
  • Northrop Grumman made up 0.2% of CX Institutional's portfolio in Q3 2026, its #123 holding.
  • CX Institutional first reported a position in Northrop Grumman in Q2 2018 and has held it in 34 quarters since.
  • 438 funds tracked by Wall St. Rank held Northrop Grumman as of Q3 2026.

Based on CX Institutional's 13F filing for Q3 2026, filed 2 Oct 2026.